These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2444718)

  • 1. Structural properties and reactivity of N-terminal synthetic peptides of herpes simplex virus type 1 glycoprotein D by using antipeptide antibodies and group VII monoclonal antibodies.
    Bosch DL; Geerligs HJ; Weijer WJ; Feijlbrief M; Welling GW; Welling-Wester S
    J Virol; 1987 Nov; 61(11):3607-11. PubMed ID: 2444718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus.
    Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS
    J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological properties of multiple repeats of a linear epitope of herpes simplex virus type 1 glycoprotein D.
    Van der Ploeg JR; Drijfhout JW; Feijlbrief M; Bloemhoff W; Welling GW; Welling-Wester S
    J Immunol Methods; 1989 Nov; 124(2):211-7. PubMed ID: 2480978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Herpes Simplex Encephalitis by ELISA Using Antipeptide Antibodies Against Type-Common Epitopes of Glycoprotein B of Herpes Simplex Viruses.
    Bhullar SS; Chandak NH; Baheti NN; Purohit HJ; Taori GM; Daginawala HF; Kashyap RS
    J Immunoassay Immunochem; 2016; 37(3):217-27. PubMed ID: 26599512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analogues of peptide 9-21 of glycoprotein D of herpes simplex virus and their binding to group VII monoclonal antibodies.
    Welling-Wester S; Feijlbrief M; Koedijk DG; Drijfhout JW; Weijer WJ; Scheffer AJ; Welling GW
    Arch Virol; 1994; 138(3-4):331-40. PubMed ID: 7527999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.
    Cohen GH; Isola VJ; Kuhns J; Berman PW; Eisenberg RJ
    J Virol; 1986 Oct; 60(1):157-66. PubMed ID: 2427745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.
    Geerligs HJ; Feijlbrief M; Bolk M; Bos CA; Drijfhout JW; Welling GW; Welling-Wester S
    Arch Virol; 1990; 114(3-4):251-8. PubMed ID: 2173527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.
    Isola VJ; Eisenberg RJ; Siebert GR; Heilman CJ; Wilcox WC; Cohen GH
    J Virol; 1989 May; 63(5):2325-34. PubMed ID: 2467994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro.
    Weijer WJ; Drijfhout JW; Geerligs HJ; Bloemhoff W; Feijlbrief M; Bos CA; Hoogerhout P; Kerling KE; Popken-Boer T; Slopsema K
    J Virol; 1988 Feb; 62(2):501-10. PubMed ID: 2826811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
    Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC
    J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D.
    Wilcox WC; Long D; Sodora DL; Eisenberg RJ; Cohen GH
    J Virol; 1988 Jun; 62(6):1941-7. PubMed ID: 2835498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein.
    Callebaut I; Burny A; Krchnák V; Gras-Masse H; Wathelet B; Portetelle D
    Virology; 1991 Nov; 185(1):48-55. PubMed ID: 1718088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
    Marlin SD; Holland TC; Levine M; Glorioso JC
    J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
    Wu CT; Levine M; Homa F; Highlander SL; Glorioso JC
    J Virol; 1990 Feb; 64(2):856-63. PubMed ID: 1688628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells.
    Cohen GH; Wilcox WC; Sodora DL; Long D; Levin JZ; Eisenberg RJ
    J Virol; 1988 Jun; 62(6):1932-40. PubMed ID: 2452897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutants.
    Muggeridge MI; Isola VJ; Byrn RA; Tucker TJ; Minson AC; Glorioso JC; Cohen GH; Eisenberg RJ
    J Virol; 1988 Sep; 62(9):3274-80. PubMed ID: 2841479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of epitopes of herpes simplex virus type 1 glycoprotein D.
    Eisenberg RJ; Long D; Ponce de Leon M; Matthews JT; Spear PG; Gibson MG; Lasky LA; Berman P; Golub E; Cohen GH
    J Virol; 1985 Feb; 53(2):634-44. PubMed ID: 2578577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies.
    Elder JH; McGee JS; Munson M; Houghten RA; Kloetzer W; Bittle JL; Grant CK
    J Virol; 1987 Jan; 61(1):8-15. PubMed ID: 2431166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D.
    Dietzschold B; Eisenberg RJ; Ponce de Leon M; Golub E; Hudecz F; Varrichio A; Cohen GH
    J Virol; 1984 Nov; 52(2):431-5. PubMed ID: 6208376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.